Entrevista a Laia Movilla, Product Specialist en Sherpapharma

Interview with Laia Movilla, Product Specialist at Sherpapharma

Today we interview Laia Movilla, the Product Specialist at Sherpapharma. Laia has a Bachelor’s degree in Biomedical Engineering from the Universitat P

Available

The last concept added to the ALCOA+ principle is Data Availability. This point is a consequence of the previous one (Data Endurance), i.e. data must

Enduring

Enduring

The third concept recently added to the ALCOA+ principle is Data Endurance. While this concept is also touched on the previous principle (Consistency)

CONSISTENT

The second concept that has been recently added to the ALCOA+ principle is Data Consistency. All data should be chronologically arranged, with time st

Complete

On 2016, documents on Data Integrity and Data Management issued by WHO (World Health Organization Working document QAS/19.819) and the PIC/S (PIC/S, D

Accuracy

Following the series of ALCOA+ publications, it is time to review last concept of classical ALCOA: Accuracy Data. A way to guarantee the accuracy of a

Original

Following the series of ALCOA+ publications, it is time to review its fourth concept: Original Data. Primary data or source data is another referral n

Contemporaneous

Following the series of ALCOA+ publications, it is time to review its third concept: Data Contemporaneous. Contemporaneous implies the recording of th

ALCOA+ second concept: Data Legibility

Following the last ALCOA+ based publication, it is time to review its second concept: Data Legibility. All pharmaceutical documents and data should be

Data integrity in the pharmaceutical industry

Over the last couple of years, data integrity has been a hot topic during pharmaceutical company audits and inspections in the wake of regulatory modi